5 A 2024 study suggests that semaglutide (GLP-1 RA) drugs may lower your cravings for sweet foods by improving taste sensitivity, changing the gene expression on your tongue thats responsible for taste perception, and even changing the way your brain responds to sweet tastes
References: Billingsley, M
A prospective study found (189) that 1 year after bariatric surgery, NASH was eliminated in 85% of patients, indicating that weight loss was closely related to the histological improvement of fatty liver
5.1 Limitations Most of the studies yet performed regarding SID and SIH employed observational designs, and data derived from randomised controlled clinical studies are lacking
A systematic review and meta-analysis published in eClinicalMedicine reported pooled mean weight regain of 5.63 kg and 5.81 percent of body weight
The goal is to make eating on a GLP-1 simple, enjoyable and sustainable while meeting your bodys needs and supporting weight loss
